TO EVALUATE THE SAFETY AND EFFICACY OF AMLODIPINE & CHLORTHALIDONE IN COMBINATION WITH TELMISARTAN IN HYPERTENSIVE PATIENTS ATTENDING TERTIARY CARE CENTRE, TELANGANA

Authors

  • VALISHETTI MANOJ KUMAR Department of Pharmacology, Osmania Medical College, Telangana, India https://orcid.org/0000-0003-3229-2848
  • YASARAPU MADHU Department of Pharmacology, Osmania Medical College, Telangana, India
  • MONICA N. Department of Pharmacology, Osmania Medical College, Telangana, India
  • LINGAMPALLY SUVID Department of Pharmacology, Osmania Medical College, Telangana, India https://orcid.org/0000-0003-2364-1057
  • NAGUR SHARONE GRACE Department of Pharmacology, Osmania Medical College, Telangana, India https://orcid.org/0000-0003-2266-8012

DOI:

https://doi.org/10.22159/ijpps.2022v14i11.46070

Keywords:

Hypertension, Telmisartan, Amlodipine, Chlorthalidone

Abstract

Objective: The main objective of this study is to evaluate and compare the effects of both treatments on systolic and diastolic blood pressure in 4th, and 8th weeks with baseline

Methods: A prospective, comparative, Open-label, and parallel-group clinical study was conducted in out patient's department of general medicine at Osmania general hospital. 120 patients were randomly allocated into 2 groups.  Group 1 with 60 patients received Tab: Telmisartan 40mg + Amlodipine 5mg once daily, and Group 2 with 60 patients received Tab: Telmisartan 40mg+ Chlorthalidone 6.25 mg once daily for a period of 8 weeks. Follow-up was done in the 4th week and 8th week to evaluate the safety and efficacy in hypertensive patients.

Results: The differences in the SBP, DBP, and HR in group A (P value <0.001) and group B (P value <0.001) at the 4th week and 8th week follow-up periods with baseline value (0 weeks) were statistically significant as P value <0.05.

Conclusion:  The combination of telmisartan plus amlodipine is equally effective as the combination of telmisartan plus chlorthalidone in decreasing SBP, DBP, HR, and MAP. No major adverse drug reactions were noted during the study period.

Downloads

Download data is not yet available.

References

Objective: The main objective of this study is to evaluate and compare the effects of both treatments on systolic and diastolic blood pressure in 4th, and 8th weeks with baseline

Methods: A prospective, comparative, Open-label, and parallel-group clinical study was conducted in out patient's department of general medicine at Osmania general hospital. 120 patients were randomly allocated into 2 groups. Group 1 with 60 patients received Tab: Telmisartan 40mg + Amlodipine 5mg once daily, and Group 2 with 60 patients received Tab: Telmisartan 40mg+ Chlorthalidone 6.25 mg once daily for a period of 8 weeks. Follow-up was done in the 4th week and 8th week to evaluate the safety and efficacy in hypertensive patients.

Results: The differences in the SBP, DBP, and HR in group A (P value <0.001) and group B (P value <0.001) at the 4th week and 8th week follow-up periods with baseline value (0 weeks) were statistically significant as P value <0.05.

Conclusion: The combination of telmisartan plus amlodipine is equally effective as the combination of telmisartan plus chlorthalidone in decreasing SBP, DBP, HR, and MAP. No major adverse drug reactions were noted during the study period.

Published

08-09-2022

How to Cite

KUMAR, V. M., Y. MADHU, M. N., L. SUVID, and N. S. GRACE. “TO EVALUATE THE SAFETY AND EFFICACY OF AMLODIPINE & CHLORTHALIDONE IN COMBINATION WITH TELMISARTAN IN HYPERTENSIVE PATIENTS ATTENDING TERTIARY CARE CENTRE, TELANGANA”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 14, no. 11, Sept. 2022, doi:10.22159/ijpps.2022v14i11.46070.

Issue

Section

Original Article(s)